A 65 year old asthama paitent comes to opd he has also diabeties mellitus type 2 and a exacreabtion of asthama attack how should i manage the paitent Genrate a ppt
Asthma DM OPD Management
Presentation · PPTX
| Slide | Content |
|---|---|
| 1 | Title slide — Patient profile (65-yr, Asthma + T2DM, acute exacerbation) |
| 2 | Initial Assessment — History, PE, objective measures (PEFR, SpO₂, BG), severity classification table |
| 3 | Acute Pharmacotherapy — SABA (salbutamol), ipratropium, systemic corticosteroids, oxygen targets; corticosteroid-hyperglycaemia warning banner |
| 4 | Diabetes Co-management — BG monitoring targets, drug interactions (β-agonists → BG↑, steroids → insulin resistance, metformin hold criteria), ADA long-term goals |
| 5 | Step-Up Controller Therapy — NHLBI 5-step visual (Step 1 SABA PRN → Step 5 high-dose ICS+LABA+OCS) with a note for this patient |
| 6 | Special Considerations — Drug cautions (avoid β-blockers, NSAIDs), inhaler technique, written action plan (Green/Yellow/Red zones), preventive vaccines |
| 7 | Disposition — Discharge criteria (PEFR >70%), admission criteria (40–70%), ICU/emergency triggers |
| 8 | Quick Reference Summary — 6-step flowchart for rapid recall |
A 65 year old asthama paitent comes to opd he has also diabeties mellitus type 2 and a exacreabtion of asthama attack how should i manage the paitent Genrate a ppt
Asthma DM OPD Management
Presentation · PPTX
| # | Slide | Key Content |
|---|---|---|
| 1 | Title | Patient profile: 65-yr, asthma + T2DM, acute exacerbation |
| 2 | Initial Assessment | History, PE, investigations (PEFR, SpO₂, BG, ABG), severity scale (Mild/Moderate/Severe/Life-threatening) |
| 3 | Acute Pharmacotherapy | SABA (salbutamol), ipratropium, systemic corticosteroids, oxygen — with a steroid-hyperglycaemia alert banner |
| 4 | Diabetes Co-management | BG monitoring frequency, antidiabetic drug adjustments (hold metformin/SGLT2, caution with SU, use SSI), long-term ADA goals |
| 5 | Stepwise Controller Therapy | NHLBI EPR-3 Steps 1–5 visual, with a note recommending Step 3 start for this patient |
| 6 | Special Considerations | Drug cautions (β-blockers, NSAIDs, ACEi, theophylline), inhaler technique, written action plan (Green/Yellow/Red zones), vaccines |
| 7 | Disposition | Discharge criteria (PEFR >70%), admission criteria (40–70%), ICU escalation (<40%, silent chest, DKA) |
| 8 | Summary Flowchart | 6-step rapid-reference guide for the entire management pathway |